VIMOVO

Riik: Iisrael

keel: inglise

Allikas: Ministry of Health

Toimeaine:

ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE 20 MG; NAPROXEN 500 MG

Saadav alates:

ASTRA ZENECA ISRAEL LTD

ATC kood:

G02CC02

Ravimvorm:

TABLETS MODIFIED RELEASE

Manustamisviis:

PER OS

Valmistatud:

ASTRA ZENECA AB., SWEDEN

Terapeutiline rühm:

NAPROXEN

Näidustused:

Vimovo is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. Vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

Loa andmise kuupäev:

2011-12-01